These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10666336)

  • 1. Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells.
    Turco A; Scarpa S; Coppa A; Baccheschi G; Palumbo C; Leonetti C; Zupi G; Colletta G
    Exp Cell Res; 2000 Feb; 255(1):77-85. PubMed ID: 10666336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.
    Scarpa S; Coppa A; Ragano-Caracciolo M; Mincione G; Giuffrida A; Modesti A; Colletta G
    Exp Cell Res; 1996 Nov; 229(1):147-54. PubMed ID: 8940258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of the transforming growth factor beta type II receptor disrupts mesoderm organisation during mouse gastrulation.
    Zwijsen A; Goumans MJ; Lawson KA; Van Rooijen MA; Mummery CL
    Dev Dyn; 1999 Feb; 214(2):141-51. PubMed ID: 10030593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.
    Adnane J; Bizouarn FA; Chen Z; Ohkanda J; Hamilton AD; Munoz-Antonia T; Sebti SM
    Oncogene; 2000 Nov; 19(48):5525-33. PubMed ID: 11114730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
    Nakamura H; Siddiqui SS; Shen X; Malik AB; Pulido JS; Kumar NM; Yue BY
    Mol Vis; 2004 Oct; 10():703-11. PubMed ID: 15475878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase (FAK) expression and activation during lens development.
    Kokkinos MI; Brown HJ; de Iongh RU
    Mol Vis; 2007 Mar; 13():418-30. PubMed ID: 17417603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
    Goumans MJ; Mummery C
    Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
    Yu Z; Xing Y
    Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tgfbeta receptor expression in lens: implications for differentiation and cataractogenesis.
    de Iongh RU; Gordon-Thomson C; Chamberlain CG; Hales AM; McAvoy JW
    Exp Eye Res; 2001 Jun; 72(6):649-59. PubMed ID: 11384153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificially accumulated beta-catenin inhibits proliferation and induces neurite extension of neuroblastoma cell line NB-1 via up-regulation of trkA.
    Sangkhathat S; Nara K; Kusafuka T; Yoneda A; Fukuzawa M
    Oncol Rep; 2006 Dec; 16(6):1197-203. PubMed ID: 17089037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
    Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
    Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.